JOSEPH LOSCALZO - 31 Jan 2022 Form 4 Insider Report for LEAP THERAPEUTICS, INC. (LPTX)

Role
Director
Signature
/s/ Douglas E. Onsi as attorney-in-fact for Joseph Loscalzo
Issuer symbol
LPTX
Transactions as of
31 Jan 2022
Transactions value $
$0
Form type
4
Filing time
02 Feb 2022, 20:50:06 UTC
Previous filing
19 Jul 2021
Next filing
06 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LPTX Stock Option (Right to Buy) Award $0 +55,000 $0 55,000 31 Jan 2022 Common Stock 55,000 $1.94 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Option was granted pursuant to Leap's 2016 Equity Incentive Plan and shall vest and become exercisable in a series of 4 quarterly installments until the Option is fully vested, with the first such quarterly installment vesting on the three-month anniversary of January 1, 2022, the Vesting Start Date.